Bionpharma Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Manufacture Generic Pharmaceuticals
PRINCETON, NJ and Tampa, FL – July 30, 2018. Bionpharma, a global biopharmaceutical company, is pleased to report the Company has signed a Definitive Agreement with CoreRx, a leading Contract Development Manufacturing Organization (CDMO), for the development and manufacturing of a number of generic dosage forms, including certain exclusive products that will be owned and sold by Bionpharma under its label. Under terms of the agreement, CoreRx will be responsible for manufacturing and supply of several pharmaceutical products, a few of which are targeted for launch beginning this year. As part of the Agreement, Bion has made a structured investment in CoreRx and has committed to certain infrastructure upgrades dedicated to support Bionpharma’s manufacturing and supply needs.
Bill Winter, one of the founders and EVP of sales and distribution for Bionpharma stated, “CoreRx is an ideal partner for Bionpharma in its quest to build a strong portfolio of products and offer affordable medicines made in the US to all the consumers. Our investment in CoreRx also gives Bionpharma reasonable control over its supply chain for the products under our agreement, which is critical to ensure uninterrupted supplies to our customers.”
Todd Daviau co-founder and President of CoreRx stated, “We are very pleased that CoreRx was chosen for this large-scale multi-year Agreement. Our knowledgeable staff, approach to technology development and cGMP compliance record allows us to serve this important partner. We will continue to closely collaborate with the Bionpharma team and help them drive their products from development to the market.”
About Bionpharma Inc.
Bionpharma is a vibrant and fast-growing generic pharmaceutical company with a strong commercial portfolio and a pipeline of generic products in the USA. With offices in Princeton, NJ and Raleigh, North Carolina, Bionpharma is one of the largest suppliers of softgel capsules in the US market with a presence in the prescription and OTC segments of the market. Bionpharma’s focus is on R&D-to develop and commercialize affordable generics in the US market by building strong and effective partnerships. More information is available at: www.bionpharma.com.
About CoreRx, Inc.
CoreRx is a Contract Development Manufacturing Organization (CDMO) with a focus on clinical phase drug product development, offering state of the art facilities to support supply chain needs throughout the entire clinical trial process. Integrated offerings provide comprehensive services for the development, manufacturing and testing of solid, liquid and semi-solid dosage forms, from pre-formulation work to final formulation development. More information is available at: www.corerxpharma.com.